secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2022-09-15T23:59:59+00:00
Accession:  0001213900-22-056294
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma implements 1-for-50 reverse stock split in preparation for Nasdaq uplisting
--------------------------------------------------------------------------------

- Reverse split at ratio of 1-for-50 effective 4:01 p.m. ET on September 14, 2022.
- Common stock will trade on OTC Markets under temporary symbol 'SILOD' until Nasdaq listing.
- Post-split shares outstanding approximately 1,987,906; fractional shares rounded up.
- Stockholders approved reverse split range at special meeting on March 11, 2022.
- Company has filed Nasdaq listing application and believes it meets all requirements except minimum share price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390022056294/0001213900-22-056294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390022056294/ea165863-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-056294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer